Thursday, December 30, 2010
Wednesday, November 24, 2010
The Bicentenary Health Congress
On October 21 and 22, The LIF was present in The Bicentenary Health Congress.
This meeting took place at the Cultural Center Bernardino Rivadavia, Rosario.
During these two days, we could attend different conferences as well as see health’s workshop of the last three years.
LIF SE was present with a stand at “The Health Square”. There, there were other stands (apart from LIF’s stand) such as IAPOS, ASSAL and ENRESS.
During these two days, over 2400 people attended the Congress.
Photo: Dr. Miguel Cappiello (Health's Minister) and Dra. Beatriz Martinelli (Biochemical's Director) with the LIF's Directors Carlos Arques, Diego Bruno and Guillermo Cleti at the LIF's stand.
This meeting took place at the Cultural Center Bernardino Rivadavia, Rosario.
During these two days, we could attend different conferences as well as see health’s workshop of the last three years.
LIF SE was present with a stand at “The Health Square”. There, there were other stands (apart from LIF’s stand) such as IAPOS, ASSAL and ENRESS.
During these two days, over 2400 people attended the Congress.
Photo: Dr. Miguel Cappiello (Health's Minister) and Dra. Beatriz Martinelli (Biochemical's Director) with the LIF's Directors Carlos Arques, Diego Bruno and Guillermo Cleti at the LIF's stand.
Wednesday, October 6, 2010
LIF WAS PRESENT ON THE 15th COFELESA’S MEETING
On Friday, September 24 the LIF’s Directors Carlos Arques and Daniel Salomón, the General Syndic Carlos Minatti and the General Manager Roberto Ganin, were present in San Juan city, on the 15th Meeting of the Federal Health Legislative Council (COFELESA, in Spanish is Consejo Federal Legislativo de Salud).
LIF’s members were invited by COFELESA, to speak about medicine public production and to give information about LIF's growth in medicine production in the last three years.
COFELESA is a federal deliberative body integrated by national and provincial lawmakers. Their main objective is to articulate and promote common policies in health.
MEETING WITH THE HEALTH MINISTRY OF SAN JUAN
LIF’s members met with the Health Ministry of San Juan, Dr. Oscar Balverdi.
In this meeting, they spoke about a future of an agreement of “Collaboration and mutual assistance” with Santa Fe’s, Dr. Miguel Cappiello.
Through this agreement, the LIF SE might provide medicines to the Health Ministry of San Juan Province when it needs it.
Photo:LIF’s membersLIF’s members with Health Ministry of San Juan, Dr. Oscar Balverdi.
LIF’s members were invited by COFELESA, to speak about medicine public production and to give information about LIF's growth in medicine production in the last three years.
COFELESA is a federal deliberative body integrated by national and provincial lawmakers. Their main objective is to articulate and promote common policies in health.
MEETING WITH THE HEALTH MINISTRY OF SAN JUAN
LIF’s members met with the Health Ministry of San Juan, Dr. Oscar Balverdi.
In this meeting, they spoke about a future of an agreement of “Collaboration and mutual assistance” with Santa Fe’s, Dr. Miguel Cappiello.
Through this agreement, the LIF SE might provide medicines to the Health Ministry of San Juan Province when it needs it.
Photo:LIF’s membersLIF’s members with Health Ministry of San Juan, Dr. Oscar Balverdi.
Monday, October 4, 2010
Tuesday, September 21, 2010
IMPORTANT AGREEMENT BETWEEN SANTA FE – ENTRE RÍOS
Santa Fe’s Governor, Hermes Binner, and Entre Ríos’ Governor, Sergio Urribarri, signed a very important agreement of “Collaboration and mutual assistance”.
The meeting took place in the White Room of the Government House in Santa Fe city, last Thursday, September 9.
The principal objective is to give mutual assistance in production and medicines provision with preference given to medicines state productions.
Therefore, the LIF SE may provide medicines to the Health Ministry of Entre Ríos Province when it needs it.
Also, both provinces will support and consult each other in matters such as technology, science, economy and business.
OTHERS SIMILAR AGREEMENTS OF SANTA FE PROVINCE.
- Agreement with the Public Health Department of Rosario. (See Two laboratories, one province)
- Agreement with the Health Ministry of Río Negro Province. (See First provision to Río Negro)
FIRST MEDICINE’S PROVISION FOR RÍO NEGRO PROVINCE
In July, the Health Ministry of Santa Fe Province gave to the Health Ministry of Río Negro Province, Amoxicilina 500 tablets LIF and Amoxicilina 250 mg pediatric powder LIF.
At the beginning of 2010, the Health Ministries of Santa Fe and Río Negro Provinces, Dr. Miguel Cappiello and Dra. Cristina Uría, respectively signed the agreement of “Colaboration and mutual assistance”.
The main objective is to give mutual assistance in production and medicines provision with preference by medicines state productions.
The Río Negro Province has a laboratory of medicine’s production, The PROZOME.
The LIF SE of Santa Fe and the PROZOME will work and will investigate cooperatively by this agreement.
Tuesday, September 7, 2010
THE LIF WAS PRESENT IN CARTA ABIERTA
On Friday, August 13 the LIF SE’s Directors Carlos Arques, Diego Bruno, Daniel Salomón, Guillermo Cleti and the General Manager Roberto Ganin, were present in the 2nd Forum organized by Carta Abierta.
This Forum was called Elaboration of Health Public Policies and took place in the Borges’s room of the National Library.
The Engineer Carlos Arques talked about “Medicines' politics from the public production”.
He started its dissertation talking about medicine public production and then he gave information about LIF's growth in medicine production in the last three years.
Finally, he talked about medicine delivery to the National Ministry during the years 2008 and 2009.
Other speakers were present at Carta Abierta, as Doctors Francisco Leone, Martín Isturiz, Ricardo Martínez and Constantino Toulupas.
THE LIF WAS PRESENT IN THE LOWER HOUSE OF NATIONAL CONGRESS
The LIF SE’s directors, the accountant Daniel Salomón and the pharmacist Guillermo Cleti went on Thursday August 12 to the public audience about State Medicine Production.
This audience was organized by the lawmakers Eduardo Macaluse and Graciela Iturraspe (SI-Unidad Popular), Claudio Lozano (Buenos Aires para todos), Mónica Fein (PS de Santa Fe) and Virginia Linares (GEN).
The LIF SE’s directors had a long talk about Santa Fe’s experience in medicine production and the production’s exchange between LIF - LEM. (To See Two laboratories, one province)
Also, they gave information about last investments made by the directory in building, technology and training people.
Wednesday, June 30, 2010
TWO LABORATORIES, ONE PROVINCE
Santa Fe plays a major part in Argentinean state medicine production. There are two state’s laboratories in the province: the Laboratorio Industrial Farmacéutico (LIF) and the Laboratorio de Especialidades Medicinales (LEM). The LIF is established in Santa Fe city whereas the LEM is established in Rosario city.
The two laboratories work and investigate cooperatively since an agreement signed in 2004. The objective of this agreement is to deliver high-quality medicine to accessible cost for the public health system. Since then, the LIF specializes in the production of beta-lactam drugs for children and adults such as amoxicillin and cefalexin. On the other hand, the LEM works on nebulizer solution salbutamol, hydrochlorothiazide, acid folic and Phenobarbital. Even though each laboratory specializes in the production of the above mentioned products, both exchange their productions and, in time, they both started producing new drugs.
Future and specialization
Nowadays, the two laboratories are planning to expand in new buildings Also, they want to be more efficient in the future so that the LIF will make alone powders and tablets as much as the LEM will make alone creams and liquids.
The two laboratories work and investigate cooperatively since an agreement signed in 2004. The objective of this agreement is to deliver high-quality medicine to accessible cost for the public health system. Since then, the LIF specializes in the production of beta-lactam drugs for children and adults such as amoxicillin and cefalexin. On the other hand, the LEM works on nebulizer solution salbutamol, hydrochlorothiazide, acid folic and Phenobarbital. Even though each laboratory specializes in the production of the above mentioned products, both exchange their productions and, in time, they both started producing new drugs.
Future and specialization
Nowadays, the two laboratories are planning to expand in new buildings Also, they want to be more efficient in the future so that the LIF will make alone powders and tablets as much as the LEM will make alone creams and liquids.
Saturday, May 15, 2010
OUR MEDICINES
MEDICINES APPROVED BY THE MINISTRY OF HEALTH OF THE PROVINCE OF SANTA FE
ANTIBIOTIC
Beta-lactam tablets:
Cefalexin 500 mg,
Amoxicillin 500 mg
Phenoxymethylpenicillin 1.5 millions
Non beta-lactam tablets:
Cotrimoxazol 400/80 mg
Eritromicin 250 mg
Beta-lactam pediatric
suspension:
Cefalexin 250 mg and 500 mg by 60, 90 and 120 ml
Amoxicillin 250 mg and 500 mg by 60, 90 and 120 ml
Beta-lactam glass ampoules
Ampicillin 1 gr (freeze-dried)
Sterile Ophthalmic drops
Gentamicin 0.3% x 10ml
ANALGESIC
Acetylsalicylic Acid 500 mg, tablets.
Paracetamol 500 mg, tablets.
Ibuprofen 400 mg, tablets.
ANTICONVULSANT
Phenobarbital 100 mg, tablets.
ANTIDIABETIC
Glibenclamide 5 mg, tablets.
Metformin 500 mg, tablets.
ANTACIDS
Ranitidine 150 mg, tablets.
ANTI HYPERTENSIVE
Atenolol 100 mg, tablets.
Enalapril 10 mg, tablets.
ANTISPASMODIC
Hyoscine Butylbromide 10 mg, tablets.
ANTIPSYCHOTICS
Haloperidol 1 mg and 5 mg, tablets
BENZODIAZEPINE DRUGS
Diazepam 5 and 10 mg, tablets.
CORTICOSTEROID
Dexamethasone 0.5 mg, tablets.
Prednisone 5 mg, tablets.
Dexamethasone 8 mg, injection
DIURETICS
Furosemide 40 mg, tablets.
Hydrochlorothiazide 50 mg, tablets.
ERECTILE DYSFUNCTION
Sildenafil 50 mg, tablets
ERGOT ALKALOIDS
Ergonovine 0.2 mg, tablets.
HORMONAL CONTRACEPTION
Levonorgestrel 0.15 mg/ ethynyl estradiol 0.03 mg, tablets.
HYPOLIPIDEMICS
Simvastatin 20 mg, tablets.
Morphine 1 %, injection
Morphine Syrup 0.2 % by 100 ml
PEDICULICIDES AND SCABICIDES
Permethrin 2.75 % cream
Permethrin 5% cream
TUBERCULOSIS TREATMENT
Isoniazid 100/300 mg tablets
Ethambutol 400 mg tablets
Rifampicin 150 mg + Isoniazid 75 mg+ Pyrazinamide 400 mg (triple association) tablets;
Rifampicin 300 mg + Isoniazid 150 mg (double association) tablets.
TREATMENT OF PARASITES
Mebendazole 100 mg, tablets.
Mebendazole 2 % by 30 ml, syrup
Metronidazole 500mg, tablets.
VITAMINS
Folic Acid 1 mg, tabletsOUR NATIONAL CERTIFICATES:
• Amoxicilina 250 mg./5 ml. x 60, 90 y 120 ml. Certificate ANMAT Nº 52296.
• Amoxicilina 500 mg./5 ml. x 60, 90 y 120 ml. Certificate ANMAT Nº 52296/2.
• Ampicilina 1 gr. ampollas. Certificate ANMAT Nº 55.202
• Cefalexina 250 mg. / 5 ml. x 60, 90 y 120 ml. Certificate ANMAT Nº 52314.
• Cefalexina 500 mg./5 ml. x 90 ml. y 120 ml. Certificate ANMAT Nº 52314/2.
• Amoxicilina 500 mg. Comp. Certificate ANMAT Nº 54.603
• Cefalexina 500 mg. Comp. Certificate ANMAT Nº 54.328
• Atenolol 100 mg. Comp. Certificate ANMAT Nº 54.599
• Enalapril 10 mg. Comp. Certificate ANMAT Nº 54.922
• Furosemida 40 mg. Comp. Certificate ANMAT Nº 53678
• Glibenclamida 5 mg. Comp. Certificate ANMAT Nº 54.228
• Hidroclorotiazida 50 mg. Comp. Certificate ANMAT Nº 54.167
• Hioscina Butil Br. 10 mg. Comp. Certificate ANMAT Nº 54.049
• Metformina 500 mg. Comp. Certificate ANMAT Nº 54.180
• Paracetamol 500 mg. Comp. Certificate ANMAT Nº 54.235
• Sinvastatina 20 mg. Comp. Certificate ANMAT Nº 54.487
• Ranitidina 150 mg. Comp. Certificate ANMAT Nº 54.403
• Mebendazol 100 mg. Comp. Certificado ANMAT Nº 55.576
• Ibuprofeno 200 mg. y 400 mg. Comp. Certificate ANMAT Nº 55.576
• Levonorgestrel/Etinilestradiol 0,15 mg - 0,03 mg. Comp. Cert. ANMAT Nº 57.213
• Morfina 10 mg Comp. Certificate ANMAT Nº 57.439
• Metadona 5 mg y 10 mg Comp. Certificate ANMAT Nº 57.473
OUR COMMUNITY
LABORATORIO INDUSTRIAL FARMACÉUTICO SOCIEDAD DEL ESTADO
AUTHORITIES
Dra. ANDREA UBOLDI
DIRECTOR: Ing. Qco. CARLOS RODOLFO ARQUES
DIRECTOR: Farm. GUILLERMO DANIEL CLETI
http://ar.linkedin.com/in/cleti
DIRECTOR: DR.JORGE STETTLER
DIRECTOR: Bioq. DIEGO RUBÉN BRUNO
TRUSTEE: Abog. HORACIO COUTAZ
GENERAL MANAGER: Ing. Qco. ROBERTO MANUEL GANIN
TECHNICAL DIRECTOR: Farm. MARIA CECILIA SELIS
Wednesday, May 5, 2010
OUR COMPANY
The Laboratorio Industrial
Farmacéutico Sociedad del Estado (LIF) is a company in the province of Santa Fe
(Argentina ),
in which the state has full ownership.
LIF was installed in 1947 to
provide for pharmacies in public hospitals, as an answer to the new health
policies of the national government and in 1987, it was officially created by
Provincial Congress.
The laboratory is a State
Society of Santa Fe as from 1999, due to Provincial Law Nº 11.657.
Today, there are more than 130 highly
specialized staff members who are trained under GMP (Good Manufacturing
Practice) regulations. The products, areas of production and quality control
also meet GMP requirements.
LIF produces different medicines for
primary healthcare in Santa Fe .
Also, LIF provides medicines to the National Health Ministry. LIF specializes in Beta-lactam
drugs and it is the first state laboratory to have a contraceptive hormonal
brand.
LIF production site has different areas of production:
- Beta-lactam tablets; non Beta-lactam tablets and Beta-lactam pediatric suspension under GMP standards and ANMAT’s approbation (ANMAT Regulation No. 8.080/11);
- Semi solid area (to produce permethrin cream) under Santa Fe province’s approbation.
- Development area.
- Beta-lactam tablets; non Beta-lactam tablets and Beta-lactam pediatric suspension under GMP standards and ANMAT’s approbation (ANMAT Regulation No. 8.080/11);
- Semi solid area (to produce permethrin cream) under Santa Fe province’s approbation.
- Development area.
Subscribe to:
Posts (Atom)